RE:RE:S&P Biotech Index Up 6.2% This Week It's just the worst comparable. What they report makes no sense, it deserves to be ignored.
Their NASH "data" is meaningless, 5 open label patients???. Their cancer data is a dog's dinner. It's clearly cherry-picked, the number of patients reported is going down rather than up even as the number of trials they are picking those patients from is going up. They are reporting astronomical numbers that mean absolutely nothing to me, I believe they are there just to make the naive go "wow".
If at any point you see comparables in any metric with thtx I'd say it's just co-incidental.
longterm56 wrote: The sad truth is that the market is treating us like CYDY ... they also post news with no reaction. I'm not saying we are anything like them, just that the market is treating us similarly. Very sad -LT
SPCEO1 wrote: THTX up 0.3%. That is obviously not good. Hopefully, a new communications effort by new staff will sort out how to get THTX on the biotech radar so that it participates in moves like this in the future. Right now, however, it is a backwater biotech stock that gets no respect.